BlackRock Science and Technology Trust Price & Performance (BST)

BlackRock Health Sciences Term Trust (BMEZ) reported that its recent tender offer, which aimed to repurchase up to 40% of its outstanding shares, was undersubscribed. Shareholders tendered nearly 38.8 million shares, below the 40.5 million share cap. All validly tendered shares are expected to be bought, with final results due April 21.12

BlackRock Science & Technology Term Trust (BSTZ) shares declined to $16.73, near their 52-week low, with a 10.4% drop over the past month. Technical indicators remain negative, and Indian investor search activity for the fund fell 13% in the last 30 days, reflecting waning interest and a challenging outlook.34

Shareholders have approved a major strategy overhaul for BlackRock’s Technology and Private Equity Term Trust, shifting it to a non-diversified structure focused on tech and private equity. The move aims to capture high-growth opportunities but increases risk, as performance will hinge on a narrower set of holdings.56